Hema reports sales rise in Q2, explores sale option

Hema’s net sales increased to 287 million euros (338 million dollars) in the second quarter of FY17, up 3.3 percent compared to the same period last year. Adjusted EBITDA reached 24.8 million euros (29 million dollars) in Q2 FY17, up 13.2 percent over Q2 FY16. The company said, it saw strong sales growth in household goods, personal care products and apparel. The company also recorded a significant increase in online sales and further improvement in gross margin. The company also announced that along with Lion Capital, it is currently exploring strategic options for the future of the company, including a possible sale.